14 studies found for:    Open Studies | spectrum pharmaceuticals
Show Display Options
Download search resultsDownload the search results for:
Open Studies | spectrum pharmaceuticals (14 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting To Evaluate the Safety and Pharmacokinetics of Belinostat in Patients Who Have Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
Conditions: Solid Tumors;   Hematological Malignancies
Interventions: Drug: Belinostat IV;   Drug: Belinostat
2 Recruiting To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
Condition: Relapsed/Refractory Solid Tumors/Hematological Malignancies
Intervention: Drug: Belinostat
3 Recruiting Study of Poziotinib in Patients With HER2-Positive Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Poziotinib
4 Recruiting RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide
Conditions: Neutropenia;   Breast Cancer
Interventions: Drug: SPI-2012;   Drug: Pegfilgrastim
5 Recruiting A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)
Condition: Peripheral T-Cell Lymphoma (PTCL)
Intervention: Drug: Pralatrexate Injection
6 Recruiting A Study of Intravesical Apaziquone as a Surgical Adjuvant in Patient Undergoing TURBT
Condition: Bladder Cancer
Interventions: Drug: Apaziquone;   Other: Placebo
7 Recruiting Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With PTCL
Conditions: Relapsed Peripheral T-Cell Lymphoma;   Refractory Peripheral T-Cell Lymphoma
Interventions: Drug: Folotyn and Leucovorin;   Drug: Folic Acid;   Drug: Vitamin B12
8 Recruiting Zevalin Post-marketing Surveillance in Japan
Condition: Non-Hodgkin's Lymphoma (NHL)
Intervention: Drug: [90]Y-ibritumomab tiuxetan (Zevalin, BAY86-5128)
9 Not yet recruiting Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab—Phase I Trial in Indolent B-cell Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma, Follicular;   Lymphoma, Mantle-Cell;   Lymphoma, Small-Cell;   Waldenstrom Macroglobulinemia;   Lymphoma, B-Cell, Marginal Zone
Interventions: Drug: Rituximab;   Drug: Bendamustine;   Drug: Vincristine sulfate liposome injection
10 Recruiting MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
Condition: Glioblastoma Multiforme of Brain
Interventions: Radiation: Standard Radiation Therapy;   Drug: Standard Temozolomide;   Drug: Belinostat
11 Recruiting Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
Conditions: Refractory Non Hodgkin Lymphoma;   Relapsed Non Hodgkin Lymphoma
Interventions: Biological: rituximab;   Biological: ibritumomab tiuxetan;   Biological: anti-thymocyte globulin;   Radiation: total nodal irradiation;   Procedure: peripheral blood stem cell transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil
12 Recruiting Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: Rituximab;   Drug: Imatinib;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Mesna;   Drug: VSLI;   Drug: Solu-Medrol;   Drug: Methotrexate;   Drug: Ara-C;   Drug: G-CSF;   Drug: Pegfilgrastim;   Drug: Dexamethasone
13 Recruiting Behavioral Treatment of Adolescent Substance Use
Condition: Substance Use Disorders
Interventions: Behavioral: Behavior Therapy;   Behavioral: Working Memory Training
14 Recruiting Pheno- & Genotyping POF (WHO III)
Conditions: Premature Ovarian Failure (POF);   Incipient Ovarian Failure;   Poor Response After Ovarian Hyperstimulation;   Early Menopause;   Hypergonadotropic Amenorrhea
Intervention:

Indicates status has not been verified in more than two years